Nian-min Shi

发表

A randomized, controlled, blinded study of the safety, immunogenicity and batch consistency of Aleph inactivated split influenza vaccine made in China in Chinese people

Shu-ming Li, Fengji Luo, Q. Lu, 2014, Human vaccines & immunotherapeutics.

Population Pharmacodynamic Analyses of Human Anti-Rabies Virus Monoclonal Antibody (Ormutivimab) in Healthy Adult Subjects

Wei Zhao, Li Li, Liqing Yang, 2022, Vaccines.

2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study

K. Chu, Zhenglun Liang, Jing-xin Li, 2017, The Journal of infectious diseases.

Safety of two doses of an inactivated hepatitis a vaccine given 6 months apart in healthy toddlers, children, and adolescents aged 12 months to 15 years in China: a phase IV study

A. Rasuli, Y. Thollot, Nian-min Shi, 2018, Human vaccines & immunotherapeutics.

Immunogenicity and safety of three 2010–2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults

Jiang Wu, Shu-ming Li, Min Lu, 2013, Human vaccines & immunotherapeutics.

Analysis of risk factors for persistent infection of asymptomatic women with high-risk human papilloma virus

Q. Lu, Zheng Zhang, Li Li, 2017, Human vaccines & immunotherapeutics.

Safety and Viral Shedding of Live Attenuated Influenza Vaccine (LAIV) in Chinese Healthy Juveniles and Adults: A Phase Ⅰ Randomized, Double-Blind, Placebo-Controlled Study

Da-wei Liu, Hui Zhao, Yu-song Zhang, 2022, Vaccines.

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Pei Liu, Fan Gao, Kai Chu, 2013, The Lancet.

Neutralizing antibody activity, safety and immunogenicity of human anti-rabies virus monoclonal antibody (Ormutivimab) in Chinese healthy adults: A phase Ⅱb randomized, double-blind, parallel-controlled study.

Hui Wang, Jian Gao, Wei Zhao, 2022, Vaccine.

Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects

Zhenggang Zhu, Yuhua Li, Ding-ming Wang, 2017, Human vaccines & immunotherapeutics.

Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above

Zijian Feng, Jianxin Ma, Jing Wang, 2017, Human vaccines & immunotherapeutics.

Immunological persistence of a seasonal influenza vaccine in people more than 3 years old

Fengji Luo, Q. Lu, Zheng Zhang, 2015, Human vaccines & immunotherapeutics.

Safety and immunogenicity of a new 13-valent pneumococcal conjugate vaccine versus a licensed 7-valent pneumococcal conjugate vaccine: a study protocol of a randomised non-inferiority trial in China

J. Chen, Rong-cheng Li, S. Yang, 2016, BMJ Open.

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial

Xiaoming Yang, Kai Duan, Wei Chen, 2022, Human vaccines & immunotherapeutics.

Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans.

Yan Liu, Dayan Wang, A. McMichael, 2011, Vaccine.

A randomized, controlled, blinded study of the safety and immunogenicity of Haemophilus influenzae type b conjugate vaccine injected at different intramuscular sites in Chinese infants

Fengji Luo, Q. Lu, Zheng Zhang, 2013, Human vaccines & immunotherapeutics.